Healthcare & Life Sciences
KaliVir Immunotherapeutics, Inc.
United States
About
KaliVir Immunotherapeutics develops immunotherapy treatments that use engineered T cell receptors to target and eliminate virus-infected or cancerous cells.
Explore KaliVir Immunotherapeutics, Inc.'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.